Home
ABVC
ABVC News

Latest ABVC BioPharma Inc. (ABVC) News on July 27, 2024

ABVC and AiBtl to Launch a New Clinical Study on Depression in Cancer Patients Using AI

NewMediaWire

18 days ago

ABVC and AiBtl to Launch a New Clinical Study on Depression in Cancer Patients Using AI

ABVC BioPharma Receives $296,000 Cash Out of Potential Aggregate License Fee of $24M Cash and Stock From Its Licensees AiBtl, ForSeeCon and OncoX in Global Licensing Deals

NewMediaWire

24 days ago

ABVC BioPharma Receives $296,000 Cash Out of Potential Aggregate License Fee of $24M Cash and Stock From Its Licensees AiBtl, ForSeeCon and OncoX in Global Licensing Deals

ABVC BioPharma Awarded ADHD Treatment Patent in Australia, a Potential $32 Billion Market

NewMediaWire

a month ago

ABVC BioPharma Awarded ADHD Treatment Patent in Australia, a Potential $32 Billion Market

ABVC BioPharma Receives First Cash Licensing Payment Anticipating $5 Million in Revenue

NewMediaWire

a month ago

ABVC BioPharma Receives First Cash Licensing Payment Anticipating $5 Million in Revenue

Immunity Boosting Combination Therapy for Myelodysplastic Syndrome (pre-Leukemia) Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Eligible to Receive Aggregate Income of $13.75M and Royalties of up to $12.50M

NewMediaWire

2 months ago

Immunity Boosting Combination Therapy for Myelodysplastic Syndrome (pre-Leukemia) Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Eligible to Receive Aggregate Income of $13.75M and Royalties of up to $12.50M

ABVC CEO's Letter to Shareholders: The Future Looks Bright for ABVC; Anticipating Cash Incomes Totaling up to $24M

NewMediaWire

2 months ago

ABVC CEO's Letter to Shareholders: The Future Looks Bright for ABVC; Anticipating Cash Incomes Totaling up to $24M

Promising Combination Therapy for Triple Negative Breast Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, Potential Income of $13.75M and Royalties of up to $12.50M

NewMediaWire

2 months ago

Promising Combination Therapy for Triple Negative Breast Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, Potential Income of $13.75M and Royalties of up to $12.50M

Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

NewMediaWire

3 months ago

Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

GlobeNewswire

3 months ago

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

GlobeNewswire

3 months ago

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M

NewMediaWire

4 months ago

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M

NewMediaWire

4 months ago

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M

AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars

GlobeNewswire

4 months ago

AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine

NewMediaWire

4 months ago

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update

NewMediaWire

4 months ago

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update

ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars

NewMediaWire

5 months ago

ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues

NewMediaWire

5 months ago

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues

ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)

GlobeNewswire

5 months ago

ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)

ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share

NewMediaWire

6 months ago

ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share

20 Countries With The Highest Number of Drug Trafficking in the World

Insider Monkey

6 months ago

20 Countries With The Highest Number of Drug Trafficking in the World

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

GlobeNewswire

6 months ago

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

PR Newswire

6 months ago

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

2024 Marks a New Era Of Pharmaceutical Innovation

Benzinga

7 months ago

2024 Marks a New Era Of Pharmaceutical Innovation

Ascendiant Capital Markets Maintains Buy Rating for Knightscope Raises Per Share Price Target to $4.00

Business Wire

7 months ago

Ascendiant Capital Markets Maintains Buy Rating for Knightscope Raises Per Share Price Target to $4.00

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees

GlobeNewswire

7 months ago

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees

How Vistagen (VTGN) Stock Stands Out in a Strong Industry

Zacks

7 months ago

How Vistagen (VTGN) Stock Stands Out in a Strong Industry

Investors Sour on EV Charging Companies

The Wall Street Journal

7 months ago

Investors Sour on EV Charging Companies

BiggerPockets Podcast Network Moves to Cumulus

GlobeNewswire

7 months ago

BiggerPockets Podcast Network Moves to Cumulus

Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors

GlobeNewswire

7 months ago

Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors

Unlocking the Future: Aware Partners with Avanza Solutions to Extend World Class Biometric Authentication Across Middle East, Asia and Africa

GlobeNewswire

7 months ago

Unlocking the Future: Aware Partners with Avanza Solutions to Extend World Class Biometric Authentication Across Middle East, Asia and Africa

Yoshitsu Co., Ltd to Report First Six Months of Fiscal Year 2024 Financial Results on Friday, December 22, 2023

GlobeNewswire

7 months ago

Yoshitsu Co., Ltd to Report First Six Months of Fiscal Year 2024 Financial Results on Friday, December 22, 2023

What Does Viemed Healthcare, Inc.'s (TSE:VMD) Share Price Indicate?

Simply Wall St.

7 months ago

What Does Viemed Healthcare, Inc.'s (TSE:VMD) Share Price Indicate?

Anixa Biosciences to Present at Biotech Showcase 2024

PR Newswire

7 months ago

Anixa Biosciences to Present at Biotech Showcase 2024

ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study

GlobeNewswire

8 months ago

ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study

Hedge Funds are Betting on These 14 Sliding Stocks

Insider Monkey

8 months ago

Hedge Funds are Betting on These 14 Sliding Stocks

ABVC BioPharma Shares Insights from Dr. Scott Irwin of Cedars-Sinai Medical Center over Depression in Cancer Patients Clinical Trials

GlobeNewswire

8 months ago

ABVC BioPharma Shares Insights from Dr. Scott Irwin of Cedars-Sinai Medical Center over Depression in Cancer Patients Clinical Trials

Gaia Appoints James Colquhoun as CEO and Launches New AI Powered Search

GlobeNewswire

8 months ago

Gaia Appoints James Colquhoun as CEO and Launches New AI Powered Search

First Guaranty Bancshares, Inc. Declares 122nd Consecutive Quarterly Cash Dividend to Shareholders

GlobeNewswire

8 months ago

First Guaranty Bancshares, Inc. Declares 122nd Consecutive Quarterly Cash Dividend to Shareholders

ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market

GlobeNewswire

8 months ago

ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market

Hanryu Holdings Reports Third Quarter and First Nine Month 2023 Financial Results

ACCESSWIRE

8 months ago

Hanryu Holdings Reports Third Quarter and First Nine Month 2023 Financial Results

ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M

GlobeNewswire

8 months ago

ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M

ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results

GlobeNewswire

8 months ago

ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript

Kolibri Global Energy Announces Third Quarter 2023 Net Income of US$2.3 Million and Adjusted EBITDA of US$9.5 Million

Business Wire

8 months ago

Kolibri Global Energy Announces Third Quarter 2023 Net Income of US$2.3 Million and Adjusted EBITDA of US$9.5 Million

The Eastern Company (NASDAQ:EML) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

The Eastern Company (NASDAQ:EML) Q3 2023 Earnings Call Transcript

LightPath Technologies, Inc. (NASDAQ:LPTH) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

LightPath Technologies, Inc. (NASDAQ:LPTH) Q1 2024 Earnings Call Transcript

Business Wire

9 months ago

GrowGeneration Reports Third Quarter 2023 Financial Results

3 Meme Stocks to Sell Immediately

InvestorPlace

9 months ago

3 Meme Stocks to Sell Immediately

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Corvus Pharmaceuticals Inc Earnings Call

Ikena Oncology to Present at Multiple November 2023 Investor Conferences

GlobeNewswire

9 months ago

Ikena Oncology to Present at Multiple November 2023 Investor Conferences

Energy Vault Announces Five Additional EVx™ Gravity Energy Storage System Deployments in China

Business Wire

9 months ago

Energy Vault Announces Five Additional EVx™ Gravity Energy Storage System Deployments in China

Associated Press Finance

9 months ago

Beasley: Q3 Earnings Snapshot

InterCure Wins Cannolam Arbitration Proceeding

GlobeNewswire

9 months ago

InterCure Wins Cannolam Arbitration Proceeding

Share on Social Networks: